0.0300USD+20.97%Mkt Cap: —P/E: —2d ago
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…
Industry Peers
Software - ApplicationKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)83.77K $
Gross Profit6.83K $
Net Income (TTM)-7.23M $
Revenue/Share0.0570 USD
Last Price0.0300 USD
Fiscal Year End—
MR Quarter—
Employees10
CountryUS
SectorTechnology
IndustrySoftware - Application
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-6.58
EPS (Forward)—
52W Range
0.02006% of range0.1800
52W High0.1800 USD
52W Low0.0200 USD
Profitability
Gross Margin9.02%
Oper. Margin-11503.18%
EBITDA Margin0.00%
Profit Margin-9551.87%
ROE-56.36%
ROA-52.91%
Growth
Revenue Growth30.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M $
CapEx (TTM)203.90K $
FCF Margin-6354.42%
FCF Yield—
Net Debt-16.30M $
Net Debt/EBITDA1.72
Balance Sheet
Debt/Equity—
Current Ratio16.20
Quick Ratio15.74
Book Value/Sh6.905 USD
Cash/Share5.653 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float2.62M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.22
S&P 52W Chg18.16%
Avg Vol (30d)35.27K
Avg Vol (10d)—
Technical Indicators
RSI (14)54.5
MACD0.0002
MACD Signal-0.0005
MACD Hist.+0.0007
BB Upper0.0312 USD
BB Middle0.0249 USD
BB Lower0.0186 USD
BB Width50.80%
ATR (14)0.0110 USD
Vol Ratio (20d)1.06x